Interestingly, the expression of RNASEH2A was found to be upregulated in CRPC, while that of RNASEH2B was downregulated in prostate cancer according to the publicly available database (Supplementary Fig. S6), as observed in a previous study (37). Here, RNASEH2A is linked to prostate carcinoma.